Lv4
408 积分 2024-07-11 加入
Efficacy and Safety of Guselkumab in Patients With Crohn’s Disease and Ulcerative Colitis: A Prospective Real-World Study
14分钟前
求助中
MBNL1 Promotes Intestinal Fibrosis via RAS-MAPK Pathway-Mediated Fibroblast Activation and Proliferation
19天前
已完结
Estrogen Receptor β Activation Mitigates Colitis-associated Intestinal Fibrosis via Inhibition of TGF-β/Smad and TLR4/MyD88/NF-κB Signaling Pathways
19天前
已完结
Mechanosensitive Ion Channel PIEZO1 as a Key Regulator of Intestinal Fibrosis in Crohn’s Disease
25天前
已完结
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials
26天前
已完结
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
1个月前
已完结
粪钙卫蛋白检测规范化及其在炎症性肠病中应用的专家共识(2025年·西安)
2个月前
已完结
中国溃疡性结肠炎诊治指南(2023年·西安)
2个月前
已完结
中国克罗恩病诊治指南(2023年·广州)
2个月前
已完结
[Chinese expert consensus on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors]
2个月前
已完结